Educational Development Partners in GHIT Fund's Innovative Mpox Detection Test Initiative

Innovative Detection Test for Mpox: A Collaborative Approach to Combat a Rising Health Threat

The Global Health Innovative Technology (GHIT) Fund announces a significant investment aimed at addressing the urgent need for improved diagnosis and management of mpox, previously known as monkeypox. With over 170,000 confirmed cases globally from January 2022 to October 2025 and a staggering case fatality ratio of 7 to 9% among children under five in the Democratic Republic of the Congo (DRC), the disease has emerged as a critical public health concern, particularly in sub-Saharan Africa. This investment of approximately JPY 70 million (USD 460,000) is targeted at developing a prototype detection test that leverages the Iso-PAS method, a genetic testing technique designed to be both cost-effective and suitable for resource-limited settings.

The necessity for rapid and accessible diagnostic methods is underscored by the inadequacies of current techniques in distinguishing between the various strains of mpox. Despite the Public Health Emergency of International Concern (PHEIC) being lifted in September 2025, the risk of severe complications and the potential for mpox to resurge remain alarming. The GHIT Fund’s collaboration with NIPRO CORPORATION, TBA Co., Ltd, the Japan Institute for Health Security (JIHS), PATH, and the Institut National de Recherche Biomédicale (INRB) aims to fill this diagnostic gap. By facilitating timely and effective treatment, the development of this prototype test hopes to curb the spread of mpox, especially in regions where healthcare resources are scarce.

This initiative reflects a broader commitment to tackling emerging infectious diseases, as demonstrated by GHIT Fund's recent membership in the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). By fostering partnerships and investing in innovative detection technologies, GHIT Fund positions itself at the forefront of global health security efforts, particularly in the context of infectious diseases that disproportionately affect vulnerable populations. The success of this project has the potential not only to improve health outcomes in affected areas but also to serve as a model for future public health initiatives aimed at combating similar threats.

In addition to this pivotal investment, the GHIT Fund's collaborative approach emphasizes the importance of cross-sector partnerships in addressing health challenges. By uniting multiple stakeholders, this initiative aims to leverage diverse expertise and resources, enhancing the overall capacity to respond to health emergencies. Moreover, the focus on developing solutions that can be implemented in resource-limited settings highlights a commitment to equity in healthcare access.

The ongoing efforts to enhance diagnostic capabilities for mpox demonstrate a proactive stance in public health preparedness. As the world continues to grapple with infectious diseases, initiatives like the GHIT Fund's investment are crucial in safeguarding communities and ensuring better health outcomes for the most vulnerable populations.